Country Club Bank Makes New $206,000 Investment in CME Group Inc. $CME

Country Club Bank bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 750 shares of the financial services provider’s stock, valued at approximately $206,000.

Other large investors also recently bought and sold shares of the company. Wayfinding Financial LLC purchased a new stake in CME Group during the 1st quarter worth approximately $25,000. Webster Bank N. A. boosted its holdings in shares of CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 60 shares during the last quarter. Cornerstone Planning Group LLC boosted its holdings in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Highline Wealth Partners LLC boosted its holdings in shares of CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares during the last quarter. Finally, Golden State Wealth Management LLC boosted its holdings in shares of CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 98 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ CME opened at $264.94 on Thursday. The company’s fifty day moving average price is $269.26 and its 200 day moving average price is $271.06. CME Group Inc. has a 1 year low of $213.94 and a 1 year high of $290.79. The company has a market capitalization of $95.48 billion, a PE ratio of 25.65, a price-to-earnings-growth ratio of 5.56 and a beta of 0.41. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the prior year, the firm posted $2.56 earnings per share. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. On average, research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio is currently 48.40%.

Wall Street Analyst Weigh In

Several analysts have recently commented on CME shares. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of CME Group in a report on Wednesday. Barclays dropped their price objective on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a report on Wednesday. JPMorgan Chase & Co. upped their price objective on shares of CME Group from $246.00 to $252.00 and gave the company an “underweight” rating in a report on Thursday, September 25th. Finally, Oppenheimer upped their price objective on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a report on Thursday, July 24th. Six equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $275.17.

Insider Activity at CME Group

In related news, Director William R. Shepard acquired 262 shares of CME Group stock in a transaction on Thursday, September 25th. The stock was bought at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the transaction, the director owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. The trade was a 0.10% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the transaction, the general counsel owned 7,851 shares of the company’s stock, valued at $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 13,043 shares of company stock valued at $3,527,956. Insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.